Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueGross MarginNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Pharming (PHAR) Return on Invested Capital (2021 - 2023)

Historic Return on Invested Capital for Pharming (PHAR) over the last 3 years, with Q2 2023 value amounting to 19.2%.

  • Pharming's Return on Invested Capital changed N/A to 19.2% in Q2 2023 from the same period last year, while for Jun 2023 it was 19.2%, marking a year-over-year change of. This contributed to the annual value of 23.98% for FY2021, which is 3027500.0% down from last year.
  • Latest data reveals that Pharming reported Return on Invested Capital of 19.2% as of Q2 2023.
  • Over the past 5 years, Pharming's Return on Invested Capital peaked at 187.25% during Q2 2021, and registered a low of 344.77% during Q3 2021.
  • Moreover, its 3-year median value for Return on Invested Capital was 19.88% (2022), whereas its average is 12.2%.
  • Within the past 5 years, the most significant YoY rise in Pharming's Return on Invested Capital was 3653400bps (2022), while the steepest drop was 207100bps (2022).
  • Pharming's Return on Invested Capital (Quarter) stood at 11.93% in 2021, then skyrocketed by 174bps to 32.64% in 2022, then plummeted by -41bps to 19.2% in 2023.
  • Its last three reported values are 19.2% in Q2 2023, 32.64% for Q4 2022, and 20.57% during Q3 2022.